Omega-3 Fatty Acids Market Growth Trajectory: Trends, Size, and Projections, 2032
Market Overview:
The global omega-3
fatty acids market size is expected to reach USD 2.24 billion by 2028,
exhibiting a CAGR of 4.80% during the forecast period. The increasing awareness
about the health benefits of polyunsaturated fatty acids (PUFA) can have
tremendous impact on the omega-3 fatty acids market growth during the forecast
period, states Fortune Business Insights in a report titled “Omega-3 Fatty
Acids Market, 2021 – 2028.” The market size stood at USD 1.54 billion
in 2020 and USD 1.62 billion in 2021.
List of Key Companies in the Market:
- Royal
DSM N.V. (Netherlands)
- Evonik
(Germany)
- BASF
SE (Germany)
- Lonza
(Switzerland)
- Epax
(Norway)
- Croda
International, Plc (U.K.)
- Cargill,
Inc. (U.S.)
- Golden
Omega (Chile)
- Corbion
(Netherlands)
- Polaris
(U.S.)
Segmentation:
Based on source, the market is classified into concentrates,
fish oil, algae oil, krill oil, and other plant sources. Based on application,
the market is divided into dietary supplements, functional/fortified foods,
infant formulae, pharmaceuticals, and animal feed & pet food. The growing popularity
of dietary supplements will boost the segment growth. Geographically, the
market is divided into North America, Europe, Asia-Pacific, South America, and
the Middle East & Africa.
Report Coverage:
The report presents In-depth information about the challenges,
opportunities, and market trends. It has elaborate details regarding the growth
drivers and obstacles that the market may come across during the forthcoming
years. It offers a list of the crucial factors impacting the market in every
region. It has an extensive analysis of the latest trends of the market.
Source: https://www.fortunebusinessinsights.com/industry-reports/omega-3-fatty-acids-market-100248
Drivers & Restraints:
Heavy Investments in R&D to Boost Omega-3 Fatty Acids
Market
Continuous technical advancements that improve the delivery
and absorption of fatty acids in the body are fueling the market's expansion.
Attributed to its bioavailability and variable absorption rate, the manufacture
of lipid-based supplements remains a difficult task. Several studies have
suggested that many factors might affect the body's ability to absorb omega
fatty acids. The market's major companies are pouring money into research &
development to create technologies that will boost omega-3 bioavailability in
the body. Pharmako Biotechnologies, for example, released a novel AquaCelle
self-emulsifying medication delivery system in October 2019.
Furthermore, processing techniques that allow omega-3 to be
extracted from new sources will increase demand for the product. Furthermore,
attempts to enhance the organoleptic qualities of fatty acids isolated from
marine sources are projected to support market expansion in the future years.
However, processing related challenges and organoleptic
properties may hinder market growth.
Regional Insights:
Growing Cognizance regarding Fatty Acids' Benefits to
Propel Market in North America
In 2020, the market size in North America was USD 0.62
billion. The region is expected to account for the highest omega-3 fatty acids
market share in the forthcoming years. The market's strong growth in North
America might be due to growing knowledge of polyunsaturated fatty acids'
beneficial health benefits. Dietary supplements and functional foods will be in
high demand in this area due to the rising prevalence of lifestyle-related
health issues, the aging population, hectic lifestyles, and stress factors.
Veganism and vegetarianism are becoming more popular in the region, resulting
in a surge in demand for omega fatty acids derived from plants. Increased
demand for omega fatty acid-containing functional foods and dietary supplements
has stemmed from a rising knowledge of the health advantages of polyunsaturated
fatty acids among European and South American clients.
Competitive Landscape:
Adoption of Partnership Strategies by Companies to
Intensify Market
Attributed to the existence of companies, such as Evonik,
BASF SE, Royal DSM N.V., Lonza & Epax, the market structure is relatively
consolidated. These large businesses are attempting to consolidate even further
by purchasing smaller participants in the market. Partnerships, partnerships,
and research and development investments are just a few of the primary measures
used by these firms to further expand their market position.
Key Development:
June 2021: OmegaQuant announced the enlargement
of its portfolio with the launch of the new Omega-3 Index Test for pets. With
this sample collection kit, pet owners can use their veterinarian to measure
their pet’s omega-3 status.
Comments
Post a Comment